tTG IgA

If you have unexplained anemia, digestive trouble that never quite gets diagnosed, or a close relative with celiac disease, this single antibody can tell you whether gluten is quietly damaging your intestine. It turns a vague suspicion into a clear, actionable answer.

Roughly 1 in 100 people have celiac disease, and most have never been diagnosed. This blood marker catches the immune reaction behind that damage, often years before symptoms force the question.

What This Antibody Actually Signals

tTG IgA (immunoglobulin A antibodies against tissue transglutaminase) measures your own immune system's misfired attack on an enzyme called tissue transglutaminase 2, which your body normally uses to repair tissue and knit proteins together. It does not measure gluten itself.

In people who carry certain genes, gluten triggers this attack in the lining of the small intestine. The antibody your immune system produces in response is what this test detects, and its level rises and falls with how active that gluten-driven reaction is.

Because the reaction damages the tiny finger-like projections that absorb nutrients (the villi), higher antibody levels generally track with more intestinal damage. That link is what makes this a window into a disease process, not just a number on a page.

Celiac Disease: The Core Association

This is the frontline blood test for celiac disease, an autoimmune condition in which gluten damages the small intestine. In people who are still eating gluten and have not yet been treated, it correctly identifies the disease in roughly 90 to 95 out of 100 cases, though real-world performance varies by laboratory and assay. It performs as well as the older, more labor-intensive antibody tests.

The height of the result matters. When your level runs at least ten times above the upper limit of normal, the chance that a biopsy would confirm celiac disease climbs to about 95 to 100 percent, especially when a second antibody test (endomysial antibody) is also positive. In many children and selected adults, that combination is now strong enough to diagnose celiac disease without a biopsy.

The connection holds in high-risk groups too. In a study of 2,035 children and adolescents with type 1 diabetes, a level at least ten times above normal predicted biopsy-confirmed celiac disease in 100 percent of screened cases, reflecting the shared autoimmune wiring between the two conditions.

Why a Normal Result Does Not Always Mean Healed

Once you remove gluten, this antibody falls, and it is widely used to check whether a gluten-free diet is working. But a normal result is reassuring, not definitive.

A meta-analysis found that in people on a gluten-free diet, a normal antibody level missed about half of those whose intestines had not actually healed. The number can look fine while damage quietly continues.

There is a useful nuance here. A truly undetectable result (below the assay's floor) lines up with a healed intestinal lining more reliably than a result that is technically negative but still detectable. If you are managing celiac disease, pushing toward undetectable is more meaningful than simply landing inside the normal range.

Signals Beyond the Gut

Elevated tTG IgA is not exclusive to celiac disease. In people with alcohol use disorder, especially those with liver disease, levels are often raised and track with liver enzymes, scarring markers, and inflammation.

One community study of 4,633 adults found that people with elevated levels had higher death rates over about nine years. Women with elevated levels were roughly four times as likely to die from any cause (hazard ratio 3.92) and about six to seven times as likely to die from cancer (hazard ratio 6.65); men showed a smaller increase. These figures were adjusted only for age, not for smoking, weight, or other habits, so they cannot prove cause and effect.

A larger community study of more than 30,000 people found no excess deaths tied to undiagnosed celiac antibodies. The sensible way to hold both findings together: an elevated result flags a real disease process, but whether it shortens life depends heavily on whether that process is found and treated. The message is not to panic over a single number, it is to investigate it.

In a cohort of 1,768 pregnant women, a positive result was linked to more celiac-related health problems in the mother (about 2.6 times the odds) and to poorer infant growth, suggesting the antibody marks active disease worth identifying during pregnancy.

Why One Reading Is Not Enough

This antibody is a moving target that responds to what you eat, which is exactly why tracking it over time beats any single snapshot. A baseline tells you where you stand; the trend tells you whether things are getting better or worse.

The response can be dramatic but slow. In 345 children starting a strict gluten-free diet, levels dropped about 14-fold within three months, yet most were still above normal at that point. Full normalization commonly takes many months to more than a year, so a single early retest can be misleading.

A practical rhythm: get a baseline while still eating gluten if celiac disease is suspected, and if you start a gluten-free diet, retest at 3 to 6 months and then at least once a year. Rising or persistently positive levels usually mean gluten is still getting in, whether you realize it or not.

What to Do With an Unexpected Result

A high result is a starting point, not a diagnosis, and the worst move is to start a gluten-free diet before the workup is done. Removing gluten too early can normalize both the antibody and the intestinal lining, erasing the evidence a doctor needs to confirm the disease. Keep eating gluten until testing is complete.

If your level is elevated, the next steps are to check total IgA (to make sure a deficiency is not distorting the result), often add the endomysial antibody test to strengthen confidence, and involve a gastroenterologist who can decide whether a biopsy is warranted. If celiac disease is confirmed, first-degree relatives should be tested too, since their risk runs far above average.

When Results Can Be Misleading

A few factors can push this test toward a false answer in either direction:

• Low total IgA: if your body makes very little IgA overall (selective IgA deficiency), this test can read falsely normal even with active celiac disease. Checking total IgA alongside it, and switching to an IgG-based test when needed, prevents a missed diagnosis.
• Avoiding gluten before testing: cutting back on gluten lowers the antibody and can mask the disease, so a reliable result requires that you have been eating gluten regularly in the weeks beforehand.
• Which lab and method ran it: different assays report different numbers for the same sample, and some methods take longer to normalize after starting a gluten-free diet, so track your trend using the same lab when you can.
• Other illnesses: liver disease, diabetes, and severe heart failure can nudge the antibody upward without celiac disease being present, which lowers the odds that a mildly elevated result means celiac in someone who is otherwise unwell.